| For: | Guo XL, Lin GJ, Zhao H, Gao Y, Qian LP, Xu SR, Fu LN, Xu Q, Wang JJ. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 2003; 9(9): 1995-1998 [PMID: 12970892 DOI: 10.3748/wjg.v9.i9.1995] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1995.htm |
| Number | Citing Articles |
| 1 |
Najibeh Shekari, Mahsa Javadian, Mottahareh Ghasemi, Behzad Baradaran, Masoud Darabi, Tohid Kazemi. Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer. Journal of Gastrointestinal Cancer 2020; 51(1) doi: 10.1007/s12029-019-00205-0
|
| 2 |
Oktay Ajikanari, Elham Miaadi, Mohaddeseh Hedayat, Reza Jafari, Rahim Asghari, Naime Majidi Zolbanin. Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells. Gene Reports 2025; 38 doi: 10.1016/j.genrep.2025.102141
|
| 3 |
Qin Huang, Shucan Wei, Jiahui Yu, Yancen Wu, Hao Lai, Wene Wei, Linhai Yan, Chenlin Su, Wei Shi, Zijie Su. The paradigm shift: re-evaluating preclinical animal models for colorectal cancer in the precision medicine era. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1744692
|
| 4 |
Lisa D. Volk, Michael J. Flister, Christopher M. Bivens, Alan Stutzman, Neil Desai, Vuong Trieu, Sophia Ran. Nab-paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced By Concurrent Anti–Vascular Endothelial Growth Factor A Therapy. Neoplasia 2008; 10(6) doi: 10.1593/neo.08302
|
| 5 |
Omar Mustafa Alghulami, Ghaith Ali Jasim, Suzan Yousif Jasim. Evaluating the docetaxel effect in an animal model of polyarthritis. Inflammopharmacology 2024; 32(3) doi: 10.1007/s10787-024-01459-2
|
| 6 |
Michael Douek, Jeffrey Tobias. How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?. Nature Clinical Practice Oncology 2005; 2(3) doi: 10.1038/ncponc0105
|
| 7 |
Ewa Maj, Diana Papiernik, Joanna Wietrzyk. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). International Journal of Oncology 2016; 49(5) doi: 10.3892/ijo.2016.3709
|
| 8 |
Sajad Fakhri, Fatemeh Abbaszadeh, Masoumeh Jorjani, Mohammad Hossein Pourgholami. The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review study. Nutrition and Cancer 2021; 73(1) doi: 10.1080/01635581.2019.1673451
|
| 9 |
F. Denis, A.V. Desbiez-Bourcier, C. Chapiron, F. Arbion, G. Body, L. Brunereau. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. European Journal of Surgical Oncology (EJSO) 2004; 30(10) doi: 10.1016/j.ejso.2004.07.024
|
| 10 |
Richard J. Epstein. VEGF signaling inhibitors: More pro-apoptotic than anti-angiogenic. Cancer and Metastasis Reviews 2007; 26(3-4) doi: 10.1007/s10555-007-9071-1
|
| 11 |
Sung Yi Hong, Myun Hee Lee, Kyung Sup Kim, Hyun Cheol Jung, Jae Kyung Roh, Woo Jin Hyung, Sung Hoon Noh, Seung Ho Choi. Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model. World Journal of Gastroenterology 2004; 10(8): 1191-1197 doi: 10.3748/wjg.v10.i8.1191
|
| 12 |
R. de Nooijer, C.J.N. Verkleij, J.H. von der Thüsen, J.W. Jukema, E.E. van der Wall, Th. J.C. van Berkel, A.H. Baker, E.A.L. Biessen. Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26(2) doi: 10.1161/01.ATV.0000197795.56960.64
|
| 13 |
Marilyn A. Roubidoux, Gerald L. LeCarpentier, J. Brian Fowlkes, Brett Bartz, Deepa Pai, Sasha P. Gordon, Anne F. Schott, Timothy D. Johnson, Paul L. Carson. Sonographic Evaluation of Early-Stage Breast Cancers That Undergo Neoadjuvant Chemotherapy. Journal of Ultrasound in Medicine 2005; 24(7) doi: 10.7863/jum.2005.24.7.885
|
| 14 |
Camila Salata, Samara Cristina Ferreira-Machado, André Luiz Mencalha, Cherley Borba Vieira de Andrade, Vera Maria Araújo de Campos, Carlos Alberto Mandarim-de-Lacerda, Carlos Eduardo deAlmeida. Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin–angiotensin system related genes in cardiac tissue. Journal of the Renin-Angiotensin-Aldosterone System 2013; 14(4) doi: 10.1177/1470320312465218
|
| 15 |
Ozge Cevik, Hilal Acidereli, Fatma Aysun Turut, Sahin Yildirim, Ceyda Acilan. Cabazitaxel exhibits more favorable molecular changes compared to other taxanes in androgen‐independent prostate cancer cells. Journal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22542
|
| 16 |
Sneha Sundaram, Ruchit Trivedi, Chandrasekar Durairaj, Rajagopal Ramesh, Balamurali K. Ambati, Uday B. Kompella. Targeted Drug and Gene Delivery Systems for Lung Cancer Therapy. Clinical Cancer Research 2009; 15(23) doi: 10.1158/1078-0432.CCR-09-1745
|
| 17 |
Poonam Yadav, Kajal Rana, Ruchira Chakraborty, Ali Khan, Devashish Mehta, Dolly Jain, Bharti Aggarwal, Somesh K. Jha, Ujjaini Dasgupta, Avinash Bajaj. Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate. Nanoscale 2024; 16(21) doi: 10.1039/D3NR04806C
|
| 18 |
Saud A Abdulsamad. Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use. American Journal of Cancer Research 2024; 14(1) doi: 10.62347/YPPT5752
|